Eurazeo Future Growth

Future criteria checks 5/6

Eurazeo is forecast to grow earnings and revenue by 36.8% and 50.7% per annum respectively. EPS is expected to grow by 40.1% per annum. Return on equity is forecast to be 11.6% in 3 years.

Key information

36.8%

Earnings growth rate

40.1%

EPS growth rate

Diversified Financial earnings growth	10.4%
Revenue growth rate	50.7%
Future return on equity	11.6%
Analyst coverage	Low
Last updated	14 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:RFP - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,562	1,019	1,459	1,875	2
12/31/2025	1,411	939	1,398	1,686	2
12/31/2024	684	880	854	1,514	2
6/30/2024	338	-77	-41	-12	N/A
3/31/2024	371	873	-32	-12	N/A
12/31/2023	405	1,824	-24	-12	N/A
9/30/2023	1,994	2,156	10	150	N/A
6/30/2023	3,583	2,488	44	311	N/A
3/31/2023	4,615	1,542	-73	282	N/A
12/31/2022	5,646	595	-190	254	N/A
9/30/2022	5,894	801	-227	165	N/A
6/30/2022	6,142	1,007	-265	76	N/A
3/31/2022	6,450	1,294	-103	196	N/A
12/31/2021	6,759	1,580	58	316	N/A
9/30/2021	6,051	1,142	64	310	N/A
6/30/2021	5,343	703	70	304	N/A
3/31/2021	4,881	271	69	303	N/A
12/31/2020	4,419	-161	69	301	N/A
9/30/2020	4,385	-303	200	416	N/A
6/30/2020	4,352	-444	330	531	N/A
3/31/2020	4,748	-165	264	505	N/A
12/31/2019	5,143	114	197	480	N/A
9/30/2019	5,125	193	109	409	N/A
6/30/2019	5,106	271	21	338	N/A
3/31/2019	5,013	280	7	290	N/A
12/31/2018	4,920	289	-7	242	N/A
9/30/2018	4,795	394	-36	184	N/A
6/30/2018	4,671	499	-66	125	N/A
3/31/2018	4,344	490	N/A	161	N/A
12/31/2017	4,017	481	N/A	196	N/A
9/30/2017	4,026	552	N/A	177	N/A
6/30/2017	4,036	624	N/A	158	N/A
3/31/2017	3,522	575	N/A	148	N/A
12/31/2016	3,009	525	N/A	138	N/A
9/30/2016	3,097	302	N/A	N/A	N/A
6/30/2016	1,389	79	N/A	42	N/A
3/31/2016	2,588	678	N/A	-139	N/A
12/31/2015	3,788	1,277	N/A	-319	N/A
9/30/2015	3,721	1,276	N/A	N/A	N/A
6/30/2015	5,452	1,276	N/A	134	N/A
3/31/2015	4,785	593	N/A	262	N/A
12/31/2014	4,118	-89	N/A	390	N/A
9/30/2014	4,255	25	N/A	522	N/A
6/30/2014	4,392	139	N/A	655	N/A
3/31/2014	4,817	350	N/A	663	N/A
12/31/2013	5,243	561	N/A	671	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RFP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: RFP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: RFP is expected to become profitable in the next 3 years.

Revenue vs Market: RFP's revenue (50.7% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: RFP's revenue (50.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: RFP's Return on Equity is forecast to be low in 3 years time (11.6%).

Eurazeo Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Investor sentiment improves as stock rises 17%

Eurazeo SE, Annual General Meeting, May 07, 2024

No independent directors

No independent directors

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

No independent directors

No independent directors

No independent directors

No independent directors

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €62.38

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.60

New 90-day high: €57.80

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

New 90-day high: €54.33

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies